CIK 0001743881 · Large accelerated filer
BridgeBio Pharma, Inc.
Sign in to watch- Ticker
- BBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (650) 391-9740
- Business address
- 3160 PORTER DR., SUITE 250, PALO ALTO, CA, 94304
- Former names
- BridgeBio Pharma LLC
- 8-K Event Results of operations
- 8-K Event Other events
- 144 Insider Sale of Securities
- 4 Other acquisition 10% owner acquired 784,720 shares (other)
- 4 Planned sale Chief Executive Officer sold 80,000 shares at an average $54.79 ($4,383,442)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Open-market sale Director sold 74,000 shares at $53.16 ($3,933,544)
- 4 Planned sale Chief Executive Officer sold 80,000 shares at an average $52.20 ($4,175,835)
- 144 Insider Sale of Securities
- 4 Open-market sale President and CFO sold 42,237 shares at $49.48 ($2,090,081)
- 4 Planned sale Chief Executive Officer sold 26,156 shares at an average $48.82 ($1,276,927)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Shares withheld for taxes Chief Accounting Officer gave up 4,781 shares (to pay taxes)
- 4 Planned sale President and CFO sold 17,353 shares at an average $50.23 ($871,722)
- 4 Shares withheld for taxes Chief Executive Officer gave up 32,855 shares (to pay taxes)
- 3 Insider Initial Statement of Ownership
- 144 Insider Sale of Securities
- SCHEDULE 13D/A Stake Beneficial Ownership Report
Page 8 of 42 · 834 filings